Search results for "34"

showing 10 items of 1830 documents

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

2020

Abstract Background The Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD; NCT03036150) trial was designed to assess the effect of the sodium–glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin on kidney and cardiovascular events in participants with CKD with and without type 2 diabetes (T2D). This analysis reports the baseline characteristics of those recruited, comparing them with those enrolled in other trials. Methods In DAPA-CKD, 4304 participants with a urinary albumin:creatinine ratio (UACR) ≥200 mg/g and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2 were randomized to dapagliflozin 10 mg once daily or placebo. Me…

MaleIGA NEPHROPATHYRATIONALEPROGRESSIONType 2 diabetesurologic and male genital diseasesDiabetic nephropathychemistry.chemical_compoundGlucosidesDESIGNMedicineFAILUREDiabetic NephropathiesDapagliflozinrandomized controlled clinical trialPrognosisfemale genital diseases and pregnancy complications//purl.org/pe-repo/ocde/ford#3.02.13 [https]Cardiovascular DiseasesNephrologyFemalesodium–glucose co-transporter-2 inhibitormedicine.symptomBENAZEPRILGlomerular Filtration Ratemedicine.medical_specialtyFinerenoneINHIBITIONNephropathy//purl.org/pe-repo/ocde/ford#3.02.20 [https]Double-Blind MethodClinical ResearchInternal medicineDiabetes mellitusEND-POINTSHumansBenzhydryl CompoundsRenal Insufficiency ChronicAcademicSubjects/MED00340Sodium-Glucose Transporter 2 InhibitorsAgedTransplantationDECLINEbusiness.industrysodium-glucose co-transporter-2 inhibitordapagliflozinmedicine.diseaseEFFICACYEditor's ChoiceDiabetes Mellitus Type 2chemistryAlbuminuriaORIGINAL ARTICLESbusinesschronic kidney diseaseKidney disease
researchProduct

Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents.

1990

Abstract Peroxisome proliferation induced by 2 hypolipidemic agents (clofibrate and ciprofibrate) was studied in rats by complementary approaches, ie cell fractionation, electron microscopy, marker enzyme activities, immunoblotting and nucleic acid hybridization techniques. Administration of clofibrates for 2 and 52 weeks in doses of 500 ppm and 50 ppm respectively, or ciprofibrate for 2,28 and 52 weeks in doses of 250, 25 and 25 ppm respectively, did not alter the behavior of the peroxisomes after induction as shown by ultracentrifugation profiles. The peroxisome mass was increased as shown by the purification procedure. Specific enzymes (catalase and mostly cyanide insensitive palmitoyl C…

MaleImmunoblottingMolecular Sequence DataPeroxisome ProliferationMitochondrionCell FractionationMicrobodiesClofibric AcidOrganellemedicineAnimalsClofibrateRNA MessengerHypolipidemic AgentsOrganellesClofibratebiologyBase SequenceEndoplasmic reticulumFibric AcidsRats Inbred StrainsCell BiologyGeneral MedicinePeroxisomeMolecular biologyRats Inbred F344RatsBiochemistryLiverCatalasebiology.proteinCiprofibrateDNA Probesmedicine.drugBiology of the cell
researchProduct

Actigraphic Sleep and Dietary Macronutrient Intake in Children Aged 6–9 Years Old: A Pilot Study

2019

The objective of this study was to examine the relationship between different sleep parameters and energy and macronutrient intake in school-aged children. A total of 203 children 6 to 9 years of age participated in this cross-sectional study. Anthropometric measurements were taken first. Diet was assessed with 3-day food logs and sleep was measured with a questionnaire on sleep quality and a wrist actigraph worn for at least 7 days. A decrease of 165.45 kcal was observed per each additional hour of sleep during the week (β (95% CI) = −165.45 (−274.01, −56.88)

MaleInfants AlimentacióCarbohydratesPhysiology030209 endocrinology & metabolismPilot Projectslcsh:TX341-641Article03 medical and health sciencesTrastorns del son en els infants0302 clinical medicinefatDietary CarbohydratesMedicineHumansChildNutricióCarbohydrate intakeNutrition and DieteticsEnergySleep qualitySleep durationbusiness.industryDietary intakeDietary intakeProteinAnthropometryProtein intakeSleep in non-human animalsActigraphyDietary FatsDietCross-Sectional StudiesFatcarbohydratesleep durationFemaleDietary ProteinsbusinessChild Nutritional Physiological PhenomenaEnergy IntakeSleepdietary intakeproteinlcsh:Nutrition. Foods and food supply030217 neurology & neurosurgeryFood ScienceSleep durationenergyNutrients
researchProduct

Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocul…

2019

UNLABELLED: PRéCIS:: Noninferiority of efficacy was demonstrated for a preservative-free latanoprost-timolol fixed combination compared with a BAK-containing formulation at 84 days after treatment in patients with open-angle glaucoma or ocular hypertension. PURPOSE: The purpose of this study was to compare the effect on intraocular pressure and safety of preservative-free latanoprost-timolol fixed combination (T2347) to benzalkonium chloride-preserved latanoprost-timolol fixed combination in patients with open-angle glaucoma or ocular hypertension. METHODS: Phase III, randomized, parallel-group, investigator-masked study in 10 countries. A total of 242 patients aged 18 years or older with o…

MaleIntraocular pressuregenetic structures:Ciencias de la Salud::Oftalmología [Materias Investigacion]Ocular hypertensionGlaucomaLatanoprost-timololT2347 Study GroupOcular hypertensionlaw.invention0302 clinical medicineRandomized controlled triallawAged 80 and overMiddle AgedDrug CombinationsTreatment OutcomeTimololLatanoprostFemalemedicine.symptomLatanoprost/timololBenzalkonium CompoundsGlaucoma Open-Anglemedicine.drugAdultmedicine.medical_specialtyOpen angle glaucomaEquivalence Trials as Topic03 medical and health sciencesTonometry OcularOphthalmologymedicineHumansPreservative-freeAdverse effectAntihypertensive AgentsIntraocular PressureAgedbusiness.industryPreservatives PharmaceuticalGlaucomamedicine.diseaseeye diseasesOphthalmology030221 ophthalmology & optometryItchingOcular Hypertensionsense organsOphthalmic Solutionsbusiness030217 neurology & neurosurgery
researchProduct

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

2019

Abstract Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with …

MaleKiller immunoglobulin-like receptors (KIRs)0301 basic medicinemedicine.medical_specialtySettore MED/09 - Medicina InternaNeurologyGenotypeT cellKIR LigandImmunologyKiller-cell immunoglobulin-like receptorchemical and pharmacologic phenomenaHuman leukocyte antigenlcsh:RC346-429Proinflammatory cytokine03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineReceptors KIRotorhinolaryngologic diseasesHumansMedicineGenetic Predisposition to DiseaseReceptorStrokelcsh:Neurology. Diseases of the nervous systemAgedSettore MED/04 - Patologia GeneraleNeuroscience (all)business.industryResearchGeneral NeuroscienceHistocompatibility Antigens Class IMiddle Agedmedicine.diseaseStrokeHLACross-Sectional Studies030104 developmental biologymedicine.anatomical_structureNeurologyImmunologyFemalebusiness030217 neurology & neurosurgeryJournal of Neuroinflammation
researchProduct

Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease

2018

Background To evaluate the clinical effectiveness of a topical sialogogue spray (malic acid, 1%) in the treatment of xerostomia in patients with chronic Graft versus Host Disease (cGVHD). Material and Methods This study was designed as a randomized double-blind clinical study. Twenty-eight patients with cGVHD suffering from xerostomia were divided into 2 groups: the first group (14 patients) received a topical sialagogue spray containing malic acid 1% (SalivAktive®) whereas the second group (14 patients) received a placebo. Both groups received treatment for 2 weeks. Dry Mouth Questionnaire (DMQ) scores and unstimulated salivary flows rate were collected before and after treatment. Results …

MaleMalatesGraft vs Host DiseaseGastroenterologylaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawSurveys and QuestionnairesMalic acidSialogogueMalic acid; Transplantation; XerostomiaOtorhinolaryngology2734 Pathology and Forensic MedicineMiddle AgedMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]Treatment OutcomeUNESCO::CIENCIAS MÉDICASFemalemedicine.symptomOral SpraysSalivationAdultmedicine.medical_specialtyClinical effectivenessmalic acidPlaceboXerostomia03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansIn patientSalivaGeneral DentistryTransplantationbusiness.industryResearchXerostomia; malic acid; transplantation; Surgery; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all)030206 dentistrymedicine.diseaseDry mouthGraft-versus-host diseaseOtorhinolaryngologychemistryDentistry (all)SurgeryMalic acidbusinesstransplantation
researchProduct

Nut Consumptions as a Marker of Higher Diet Quality in a Mediterranean Population at High Cardiovascular Risk

2019

Background: Nut consumption has been associated with improved nutrient adequacy and diet quality in healthy adult populations but this association has never been explored in individuals at high cardiovascular risk. Objective: to assess the associations between consumption of nuts and nutrient adequacy and diet quality in a Mediterranean population at high cardiovascular risk. Design: baseline assessment of nutritional adequacy in participants (n = 6060, men and women, with ages 55&ndash

MaleMediterranean diet030309 nutrition & dieteticsnut consumptionhumanosOverweightDiet Mediterranean0302 clinical medicineRisk FactorsNutsMicronutrientsmediana edad2. Zero hungerMetabolic Syndromeanciano0303 health scienceseducation.field_of_studyNutrition and Dieteticsencuestas de nutricióndietadigestive oral and skin physiologyfood and beveragesdiet qualityMiddle AgedMicronutrientNutrition Surveys3. Good healthestado nutricionalCardiovascular diseasesDietary Reference IntakeCardiovascular DiseasesCuina (Nous)Femalemedicine.symptomCooking (Nuts)lcsh:Nutrition. Foods and food supplynutrient adequacyNutPopulationenfermedades cardiovascularesMediterranean diet cardiovascular risk disease diet quality nut consumption nutrient adequacyNutritional Statuslcsh:TX341-641030209 endocrinology & metabolismArticlecardiovascular risk disease03 medical and health sciencesMediterranean cooking:Ciencias de la Salud::Medicina preventiva [Materias Investigacion]Environmental healthMediterranean dietCuina mediterràniaingesta energéticamedicinefactores de riesgoHumansObesityeducationobesidadAgedbusiness.industryMalalties cardiovascularsmicronutrientesmediterranean dietmedicine.diseaseObesityDietnuecesMetabolic syndromebusinessEnergy IntakeFood Science
researchProduct

Adherence to the Mediterranean Lifestyle and Desired Body Weight Loss in a Mediterranean Adult Population with Overweight: A PREDIMED-Plus Study

2020

Background. Body weight dissatisfaction is a hindrance to following a healthy lifestyle and it has been associated with weight concerns. Objectives. The aim of this study was to assess the association between the adherence to the Mediterranean lifestyle (diet and exercise) and the desired body weight loss in an adult Mediterranean population with overweight. Methods. Cross-sectional analysis in 6355 participants (3268 men; 3087 women) with metabolic syndrome and BMI (Body mass index) between 27.0 and 40.0 kg/m2 (55–75 years old) from the PREDIMED-Plus trial. Desired weight loss was the percentage of weight that participants wished to lose. It was categorized into four cut-offs of this perce…

MaleMediterranean dietObesidadejercicio físicoBody Mass Index:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]0302 clinical medicineSurveys and QuestionnairesAntineoplastic Combined Chemotherapy ProtocolsMedicinemediana edadeducation.field_of_studyanciano:Health Care::Health Care Quality Access and Evaluation::Quality of Health Care::Epidemiologic Factors::Age Factors [Medical Subject Headings]dietaprotocolos de quimioterapia antineoplásica combinada3. Good healthOlder adultsmetotrexatoprogramas de reducción de pesoObesitatlcsh:Nutrition. Foods and food supplyPersonas mayores frágilesIdeal weightLifestyles:Check Tags::Male [Medical Subject Headings]lcsh:TX341-641ArticleEstilo de vida03 medical and health sciences:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight [Medical Subject Headings]:Anthropology Education Sociology and Social Phenomena::Human Activities::Exercise [Medical Subject Headings]ifosfamidaHumanscisplatinoIfosfamideeducationExerciseAgedconducta alimentaria:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Metabolic Syndrome X [Medical Subject Headings]:Persons::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings]:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style [Medical Subject Headings]PREDIMED-Plusmedicine.diseaseObesityMethotrexate:Check Tags::Female [Medical Subject Headings]Desired weight lossMetabolic syndromeCisplatinBody mass indexDemographyobesitycumplimiento del pacientehumanos:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]Ideal Body Weightdesired weight loss:Health Care::Health Care Facilities Manpower and Services::Health Promotion::Weight Reduction Programs [Medical Subject Headings]OverweightDiet MediterraneanMediterranean lifestyle:Health Care::Health Care Facilities Manpower and Services::Health Services::Preventive Health Services::Health Promotion::Healthy People Programs [Medical Subject Headings]Weight loss030212 general & internal medicine:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Health Behavior::Patient Compliance [Medical Subject Headings]Abdominal obesityolder adults:Persons::Persons::Age Groups::Adult::Aged [Medical Subject Headings]2. Zero hungerNutrition and Dieteticsmediterranean lifestylesobrepeso:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Nutrition Therapy::Diet Therapy::Diet Mediterranean [Medical Subject Headings]Age Factorsideal weightMiddle AgedPeso corporal ideal:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Ideal Body Weight [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies [Medical Subject Headings]Weight Reduction ProgramsBody imageFemalemedicine.symptompeso corporal idealEstils de vidadoxorrubicinabody imagePopulationImagen corporal030209 endocrinology & metabolism:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Feeding Behavior [Medical Subject Headings]overweightHealthy LifestyleObesity:Geographical Locations::Geographic Locations::Europe::Spain [Medical Subject Headings]business.industryíndice de masa corporalFeeding BehaviorOverweightDieta mediterráneaDietDoxorubicinSobrepesoPatient Compliance:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Perception::Body Image [Medical Subject Headings]businessFood Science
researchProduct

Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the PREDIMED Study

2015

Previous studies have reported an association between a more pro-inflammatory diet profile and various chronic metabolic diseases. The Dietary Inflammatory Index (DII) was used to assess the inflammatory potential of nutrients and foods in the context of a dietary pattern. We prospectively examined the association between the DII and the incidence of cardiovascular disease (CVD: myocardial infarction, stroke or cardiovascular death) in the PREDIMED (Prevención con Dieta Mediterránea) study including 7216 high-risk participants. The DII was computed based on a validated 137-item food frequency questionnaire. Multivariate-adjusted hazard ratios (HR) and 95% confidence intervals of CVD risk we…

MaleMediterranean dietmodelos de riesgos proporcionaleshumanosSistema cardiovascular -- Malaltiesestudios de seguimientoDiet MediterraneanDietary inflammatory indexBody Mass Indexcardiovascular diseaseRisk Factorsestudios prospectivosSurveys and QuestionnairesNutsProspective StudiesProspective cohort studymediana edadAged 80 and overancianoNutrition and Dieteticsdietaresultado del tratamientoIncidenceIncidence (epidemiology)Hazard ratioMiddle AgedCardiovascular diseaseInflamaciódeterminación del punto finalCardiovascular diseasesTreatment OutcomeQuartileCardiovascular Diseasesdietary inflammatory indexFemalelcsh:Nutrition. Foods and food supplyPREDIMEDmedicine.medical_specialtyEndpoint DeterminationPromoció de la salutenfermedades cardiovasculareslcsh:TX341-641Context (language use):Ciencias de la Salud::Nutrición y dietética [Materias Investigacion]incidenciaArticleMediterranean cookinginflamaciónInternal medicineCuina mediterràniaingesta energéticamedicinefactores de riesgoHumansanálisis multifactorialOlive OilAgedProportional Hazards ModelsInflammationMalalties cardiovascularsbusiness.industryProportional hazards modelíndice de masa corporalDietSurgerynuecesMultivariate AnalysisHealth promotionEnergy IntakebusinessBody mass indexFollow-Up StudiesFood ScienceNutrients
researchProduct

Dysfunction of attention switching networks in amyotrophic lateral sclerosis

2019

Objective To localise and characterise changes in cognitive networks in Amyotrophic Lateral Sclerosis (ALS) using source analysis of mismatch negativity (MMN) waveforms. Rationale The MMN waveform has an increased average delay in ALS. MMN has been attributed to change detection and involuntary attention switching. This therefore indicates pathological impairment of the neural network components which generate these functions. Source localisation can mitigate the poor spatial resolution of sensor-level EEG analysis by associating the sensor-level signals to the contributing brain sources. The functional activity in each generating source can therefore be individually measured and investigat…

MaleMismatch negativitySource localisationEEG ElectroencephalographyMismatch negativityNetworkElectroencephalographylcsh:RC346-429PET Positron emission tomographyCognition0302 clinical medicineC9orf72AttentionEEGAUROC Area under receiver operating characteristic curveAmyotrophic lateral sclerosisAged 80 and overmedicine.diagnostic_test05 social sciencesCognitive flexibilityBrainRegular ArticleElectroencephalographyCognitionMiddle AgedSTG Superior temporal gyrusNeurologyMTG Mid temporal gyrusDLPFC Dorsolateral prefrontal cortexlcsh:R858-859.7FemaleLCMV Linearly constrained minimum varianceIFG Inferior frontal gyrusAdultCognitive Neurosciencelcsh:Computer applications to medicine. Medical informatics050105 experimental psychologyCWIT Colour-word interference test03 medical and health sciencesfMRI Functional magnetic resonance imagingMEG MagnetoencephalographymedicineMMN Mismatch negativityHumans0501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingLS Amyotrophic Lateral SclerosisAAL Automated Anatomical Labellinglcsh:Neurology. Diseases of the nervous systemAEP Auditory evoked potentialAgedbusiness.industryAmyotrophic Lateral SclerosisIQR Interquartile rangeNeurophysiologyqEEG Quantitative EEGmedicine.diseaseNeurology (clinical)Nerve NetFunctional magnetic resonance imagingbusinessNeuroscience030217 neurology & neurosurgeryeLORETA Exact low-resolution brain electromagnetic tomographyNeuroImage: Clinical
researchProduct